Document Detail


Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial.
MedLine Citation:
PMID:  20484099     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: In the COREA-TAXUS trial ("Effect of Celecoxib On REstenosis after coronary Angioplasty with a TAXUS stent"), celecoxib reduced late luminal loss and adverse cardiac events at follow-up around 6 months. The objective of this study was to assess the long-term outcome of short-term adjunctive celecoxib treatment after paclitaxel-eluting stent implantation. METHODS AND RESULTS: This is a 2-year clinical follow-up of the COREA-TAXUS trial, an open-label randomized controlled study. A total 274 patients were randomized to receive or not receive celecoxib (400 mg before the intervention and 200 mg twice daily for 6 months after the procedure), and 271 underwent successful paclitaxel-eluting stent implantation. All patients were given aspirin (100 mg daily indefinitely) and clopidogrel (75 mg daily for at least 6 months). Among the 271 patients, 267 (98.5%) completed the 2-year clinical follow-up. From the previous follow-up to 2 years, there was no difference in the rate of adverse cardiac events between the celecoxib and control groups (1.6% versus 4.3%, P=0.27). Thus, at 2 years, the rate of adverse cardiac events was consistently lower in the celecoxib group (6.9% versus 19.7%, P=0.002). A significant reduction in need for target lesion revascularization was observed (6.2% versus 18.2%, P=0.003). The efficacy benefit in the celecoxib group was not undermined by an increased risk for cardiac death or myocardial infarction at 2 years (1.5% versus 1.4%). CONCLUSIONS: Six-month adjunctive celecoxib treatment after paclitaxel-eluting stent implantation was associated with durable long-term efficacy up to 2 years. However, the inconclusive evidence for the long-term safety of this treatment warrants caution. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT 00292721.
Authors:
Jin-Wook Chung; Han-Mo Yang; Kyung-Woo Park; Hae-Young Lee; Jin-Shik Park; Hyun-Jae Kang; Young-Seok Cho; Tae-Jin Youn; Bon-Kwon Koo; In-Ho Chae; Dong-Ju Choi; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Related Documents :
20102389 - Elective single-vessel percutaneous coronary intervention in a vegetative state patient.
8496519 - Serial angiographic follow-up after palmaz-schatz stent implantation: comparison with c...
20465719 - Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (eos) study.
22012529 - Early results of reverse shoulder arthroplasty in patients with rheumatoid arthritis.
20031899 - Temporal trends in patient-reported angina at 1 year after percutaneous coronary revasc...
8726169 - Effect of cilostazol, a novel anti-platelet drug, on restenosis after percutaneous tran...
8661629 - Disadvantages of muscle-sparing thoracotomy in patients with lung cancer.
20561169 - Sexual function after sacrocolpopexy.
21258779 - A comparison of early versus delayed repair of traumatic rotator cuff tears.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-18
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  3     ISSN:  1941-7632     ISO Abbreviation:  Circ Cardiovasc Interv     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  243-8     Citation Subset:  IM    
Affiliation:
Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00292721
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospita...
Next Document:  Catheter-Based Left Atrial Appendage (LAA) Ligation for the Prevention of Embolic Events Arising Fro...